| Monocyte chemotactic protein‐1 (MCP‐1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion Y Lu, Z Cai, DL Galson, G Xiao, Y Liu, DE George, MF Melhem, Z Yao, ... The Prostate 66 (12), 1311-1318, 2006 | 311 | 2006 |
| Multiple roles of chemokine (CC motif) ligand 2 in promoting prostate cancer growth J Zhang, Y Lu, KJ Pienta Journal of the National Cancer Institute 102 (8), 522-528, 2010 | 249 | 2010 |
| Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism J Dai, J Keller, J Zhang, Y Lu, Z Yao, ET Keller Cancer research 65 (18), 8274-8285, 2005 | 247 | 2005 |
| FoxO1 links insulin resistance to proinflammatory cytokine IL-1β production in macrophages D Su, GM Coudriet, D Hyun Kim, Y Lu, G Perdomo, S Qu, S Slusher, ... Diabetes 58 (11), 2624-2633, 2009 | 212 | 2009 |
| Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3‐E1 cells and primary mouse bone marrow stromal cells UK Singha, Y Jiang, S Yu, M Luo, Y Lu, J Zhang, G Xiao Journal of cellular biochemistry 103 (2), 434-446, 2008 | 204 | 2008 |
| Monocyte chemotactic protein-1 mediates prostate cancer–induced bone resorption Y Lu, Z Cai, G Xiao, ET Keller, A Mizokami, Z Yao, GD Roodman, J Zhang Cancer research 67 (8), 3646-3653, 2007 | 198 | 2007 |
| Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent … L Wallner, J Dai, J Escara-Wilke, J Zhang, Z Yao, Y Lu, M Trikha, ... Cancer research 66 (6), 3087-3095, 2006 | 182 | 2006 |
| Soluble receptor activator of nuclear factor κB Fc diminishes prostate cancer progression in bone J Zhang, J Dai, Z Yao, Y Lu, W Dougall, ET Keller Cancer research 63 (22), 7883-7890, 2003 | 178 | 2003 |
| Metformin targets multiple signaling pathways in cancer Y Lei, Y Yi, Y Liu, X Liu, ET Keller, CN Qian, J Zhang, Y Lu Chinese journal of cancer 36, 1-9, 2017 | 162 | 2017 |
| CCR2 expression correlates with prostate cancer progression Y Lu, Z Cai, G Xiao, Y Liu, ET Keller, Z Yao, J Zhang Journal of cellular biochemistry 101 (3), 676-685, 2007 | 162 | 2007 |
| Emerging role of tumor cell plasticity in modifying therapeutic response S Qin, J Jiang, Y Lu, EC Nice, C Huang, J Zhang, W He Signal transduction and targeted therapy 5 (1), 228, 2020 | 155 | 2020 |
| CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway J Wang, Y Lu, J Wang, AE Koch, J Zhang, RS Taichman Cancer research 68 (24), 10367-10377, 2008 | 148 | 2008 |
| Wnt3a: functions and implications in cancer S He, Y Lu, X Liu, X Huang, ET Keller, CN Qian, J Zhang Chinese journal of cancer 34, 1-9, 2015 | 127 | 2015 |
| Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone Y Lu, Q Chen, E Corey, W Xie, J Fan, A Mizokami, J Zhang Clinical & experimental metastasis 26, 161-169, 2009 | 119 | 2009 |
| CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro Y Lu, J Wang, Y Xu, AE Koch, Z Cai, X Chen, DL Galson, RS Taichman, ... Molecular Cancer Research 6 (4), 546-554, 2008 | 106 | 2008 |
| Monocyte chemotactic protein 1 promotes lung cancer–induced bone resorptive lesions in vivo Z Cai, Q Chen, J Chen, Y Lu, G Xiao, Z Wu, Q Zhou, J Zhang Neoplasia 11 (3), 228-236, 2009 | 97 | 2009 |
| Mangiferin attenuates TH1/TH2 cytokine imbalance in an ovalbumin-induced asthmatic mouse model HW Guo, CX Yun, GH Hou, J Du, X Huang, Y Lu, ET Keller, J Zhang, ... PloS one 9 (6), e100394, 2014 | 93 | 2014 |
| Exosome-derived microRNAs contribute to prostate cancer chemoresistance J Li, X Yang, H Guan, A Mizokami, ET Keller, X Xu, X Liu, J Tan, L Hu, ... International journal of oncology 49 (2), 838-846, 2016 | 91 | 2016 |
| Upregulation of NEK2 is associated with drug resistance in ovarian cancer X Liu, Y Gao, Y Lu, J Zhang, L Li, F Yin Oncology reports 31 (2), 745-754, 2014 | 88 | 2014 |
| Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling W Wang, L Wang, A Mizokami, J Shi, C Zou, J Dai, ET Keller, Y Lu, ... Chinese journal of cancer 36, 1-13, 2017 | 84 | 2017 |
